| Ytd | 11.87% | |
| 1y | 202.57% |
| Open | 31.92 | Prev Close | 31.94 | Low | 29.27 | High | 32.30 | Mkt Cap | 1.75B |
| Vol | 741.25K | Avg Vol | 991.59K | EPS | -2.18 | P/E | N/A | Forward P/E | -11.33 |
| Beta | 0.75 | Short Ratio | 10.67 | Inst. Own | 111.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 32.12 | 200-d Avg | 26.92 | 1yr Est | 51.97 |
Analysts change outlook on top Wall Street names. SNX, ORCL, EDU, ENS, SHOO, RH, have price target c
Top Wall Street analysts changed outlook on top names. See full list of rating changes on analyst ra
Wall Street analysts change outlook on top names, including upgrades/downgrades. Check our analyst r
B of A Securities analyst Geoff Meacham maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and r